Abstract
Background: We investigated the effect of novel highly active necroptosis inhibitors, necrosulfonamide (NSA) and necrostatin-1s (Nec-1s), on myocardial tolerance to ischemia-reperfusion injury (IRI). Methods: The isolated Langendorff-perfused rat hearts were subjected to 35-min global ischemia
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
